Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their

Daniela Latorre1, Nadia Pulvirenti2, Daniela Angela Covino3

  • 1Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Viale Regina Elena 299, Rome 00161, Italy. daniela.latorre@irb.usi.ch.

Toxins
|December 24, 2015
PubMed

Insights

Bovine lactoferrin (bLF) boosts CCL1 chemokine secretion in monocytes and dendritic cells by engaging different receptors. This differential response highlights bLF's complex immunomodulatory role.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Lactoferrin (LF) is known for its immunomodulatory properties, including the regulation of cytokine and chemokine secretion.
  • Monocytes (Mo) differentiate into dendritic cells (DCs), key players in the immune system.

Purpose of the Study:

  • To investigate the effect of bovine lactoferrin (bLF) on CCL1 secretion in monocytes and monocyte-derived dendritic cells (MoDCs).
  • To elucidate the specific cell surface receptors involved in bLF-mediated CCL1 modulation.

Main Methods:

  • Monocytes and MoDCs were treated with bLF.
  • CCL1 secretion and transcript levels were measured.
  • Blocking studies using antibodies against CD36 and toll-like receptor (TLR)2 were performed.

Main Results:

  • bLF significantly increased CCL1 secretion and transcript accumulation in a concentration- and time-dependent manner in both monocytes and MoDCs.
  • CD36 engagement was crucial for bLF-induced CCL1 upregulation in differentiating monocytes.
  • TLR2 blocking markedly reduced bLF-induced CCL1 production in MoDCs.

Conclusions:

  • bLF differentially modulates CCL1 secretion in monocytes and MoDCs through distinct surface receptors (CD36 and TLR2, respectively).
  • These findings underscore the cell-specific immunomodulatory effects of bLF.
  • The differential responses may have implications for bLF's role in various physiological and pathological conditions.